Market Highlights
The Laboratory Equipment Market size was valued at USD 35.20 Billion in 2025, and the market is projected to grow from USD 38.09 Billion in 2026 to USD 77.42 Billion by 2035, registering a CAGR of 8.2% during the forecast period 2026–2035.
The market growth is primarily driven by rising research activities in the pharmaceutical and biotechnology industries, increased healthcare expenditure, and the growing prevalence of chronic diseases such as cancer, cardiovascular disorders, and diabetes. Technological innovations such as automation, AI-based data analytics, and smart diagnostic solutions are also reshaping laboratory operations worldwide.
A lot of money is being put into improving the infrastructure of labs. For example, Siemens Healthineers opened its Centre of Excellence in Ireland, which focuses on new diagnostic technologies, and Revvity launched its Signals Research Suite to improve the way research is done. These programs should help labs become more innovative and efficient more quickly.
Additionally, the global healthcare sector’s projected expenditure of USD 10 trillion by 2024—with a significant focus on diagnostics—further highlights the growing demand for sophisticated laboratory equipment.
MRFR recognizes the following companies as the key players in the Global Laboratory Equipment Market — Thermo Fisher Scientific Inc., Agilent Technologies Inc., BD, Beckman Coulter Inc., Bio-Rad Laboratories Inc., and Bruker.
Segment Analysis
By Product Type
The Global Laboratory Equipment Market segmentation, based on product type, includes Incubators, Centrifuges, Spectrometers, Scopes, Sonicators, Autoclaves, and Others.Among these, the Incubators segment dominates the market due to their high cost and essential role in critical research areas such as cell and tissue culture, drug discovery, and oncology studies. The increasing adoption of technologically advanced and energy-efficient incubators further drives this segment’s growth.
Region Analysis
By Region, the Global Laboratory Equipment Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.
North America accounted for USD 20.54 billion in 2024 and is expected to exhibit significant growth during the study period. This is attributed to increased government and private funding for research institutions, the strong presence of key industry players, and advanced healthcare infrastructure.
Europe held the second-largest market share due to the widespread adoption of modern diagnostic technologies and well-established research networks. Germany leads the region, while the UK is expected to be the fastest-growing market.
The Asia-Pacific region is projected to grow at the fastest CAGR from 2025 to 2035. Growth is driven by rising biotech investments, expansion of CROs, and increased import and adoption of laboratory equipment in countries like China and India.
Key Findings of the Study
- Laboratory equipment captured roughly 51% of the Laboratory Equipment Market revenue in 2025, reflecting sustained capital spending on automated analyzers and imaging platforms.
- Laboratory disposables are forecast to expand at a 10.3% CAGR through 2035, driven by single-use bioreactor linings and pre-sterilized consumable kits.
- Clinical diagnostics led the Laboratory Equipment Market with approximately 38% of spending in 2025, underpinned by hospital-based chemistry and hematology volumes.
- Genomics and proteomics applications are set to advance at a 10.5% CAGR, fueled by precision-medicine adoption and next-generation sequencing cost reductions.